Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Large plantar mass in a newborn.
Galbraith SS, King DM, Drolet BA, Esterly NB. Galbraith SS, et al. Among authors: king dm. Pediatr Dermatol. 2006 Jan-Feb;23(1):84-6. doi: 10.1111/j.1525-1470.2006.00179.x. Pediatr Dermatol. 2006. PMID: 16445422 No abstract available.
Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.
Drolet BA, Trenor CC 3rd, Brandão LR, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM. Drolet BA, et al. Among authors: king dm. J Pediatr. 2013 Jul;163(1):285-91. doi: 10.1016/j.jpeds.2013.03.080. J Pediatr. 2013. PMID: 23796341 No abstract available.
Mimickers of Infantile Hemangiomas.
Brockman RM, Humphrey SR, Moe DC, North PE, King DM, Jensen JN, Siegel DH, Drolet BA. Brockman RM, et al. Among authors: king dm. Pediatr Dermatol. 2017 May;34(3):331-336. doi: 10.1111/pde.13127. Pediatr Dermatol. 2017. PMID: 28523875
Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics.
Siegel DH, Cottrell CE, Streicher JL, Schilter KF, Basel DG, Baselga E, Burrows PE, Ciliberto HM, Vigh-Conrad KA, Eichenfield LF, Holland KE, Hogeling M, Jensen JN, Kelly ME, Kim W, King DM, McCuaig C, Mueller KA, Pope E, Powell J, Price H, Steiner JE, Frieden IJ, Tollefson MM, Drolet BA. Siegel DH, et al. Among authors: king dm. J Invest Dermatol. 2018 Apr;138(4):957-967. doi: 10.1016/j.jid.2017.10.033. Epub 2017 Nov 22. J Invest Dermatol. 2018. PMID: 29174369 Free article.
Scarring in Patients With PIK3CA-Related Overgrowth Syndromes.
Steiner JE, Cottrell CE, Streicher JL, Jensen JN, King DM, Burrows PE, Siegel DH, Tollefson MM, Drolet BA, Püttgen KB. Steiner JE, et al. Among authors: king dm. JAMA Dermatol. 2018 Apr 1;154(4):452-455. doi: 10.1001/jamadermatol.2017.6189. JAMA Dermatol. 2018. PMID: 29516089 Free PMC article.
Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.
King DM, Albertini MR, Schalch H, Hank JA, Gan J, Surfus J, Mahvi D, Schiller JH, Warner T, Kim K, Eickhoff J, Kendra K, Reisfeld R, Gillies SD, Sondel P. King DM, et al. J Clin Oncol. 2004 Nov 15;22(22):4463-73. doi: 10.1200/JCO.2004.11.035. Epub 2004 Oct 13. J Clin Oncol. 2004. PMID: 15483010 Free PMC article. Clinical Trial.
195 results